Fujimoto Pharmaceutical (601089.SH): Amlodipine Benazepril Capsules Obtain Drug Registration Certificate.

Zhtng Cijng APP News, Fuyuan Pharmaceuticals (601089.SH) announced that the company has recently received the "Drug Registration Certificate" (Certificate Number: 2025S02582) issued by the National Medical Products Administration (referred to as the "National Medical Administration") for Amlodipine Benazepril Capsules (specifications: each capsule containing 5mg of Amlodipine Besylate (calculated as C20H25ClN2O5) and 10mg of Benazepril Hydrochloride), approving the production of the drug.